Literature DB >> 10594694

Regulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallings.

H Ochi1, H Takeshita, T Suda, S Nisitani, T Honjo, T Watanabe.   

Abstract

The src-family protein tyrosine kinase, Lyn, has been reported to play a crucial role in the regulation of B-cell antigen receptor (BCR)-mediated signalling. To elucidate the role of Lyn in the maintenance of immunological tolerance and the prevention of B-1 cell activation and its autoantibody production, Lyn-deficient mice were crossed with transgenic mice carrying the immunoglobulin heavy and light chain genes encoding an autoantibody against mouse red blood cells. In the transgenic mice, most peripheral B cells expressed the B-1 cell phenotype. When the transgenic mice were bred in specific pathogen-free (SPF) conditions, B-1 cells were anergic and did not produce any autoantibody. In contrast, Lyn-deficient transgenic mice kept in the same SPF conditions revealed markedly increased numbers of activated B-1 cells and developed severe autoimmune haemolytic anaemia. Moreover, the mice had a huge splenomegaly containing a remarkable accumulation of erythroblasts, resulted from extramedullary erythropoiesis, in addition to the increased numbers of lymphoblast-like cells of the B-1 cell lineages. The present study demonstrates a crucial role of Lyn kinase in the regulation of B-1 cell activation and maintenance of tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594694      PMCID: PMC2326971          DOI: 10.1046/j.1365-2567.1999.00899.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice.

Authors:  M Murakami; T Tsubata; M Okamoto; A Shimizu; S Kumagai; H Imura; T Honjo
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

3.  A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells.

Authors:  K Ikuta; T Kina; I MacNeil; N Uchida; B Peault; Y H Chien; I L Weissman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

4.  Development and physiology of Ly-1 B and its human homolog, Leu-1 B.

Authors:  R R Hardy; K Hayakawa
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

5.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

Review 6.  B-cell lineages exist in the mouse.

Authors:  L A Herzenberg; A B Kantor
Journal:  Immunol Today       Date:  1993-02

7.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

8.  Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.

Authors:  K Hayakawa; R R Hardy; M Honda; L A Herzenberg; A D Steinberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes.

Authors:  D L Morris; T L Rothstein
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

10.  A transgenic model of autoimmune hemolytic anemia.

Authors:  M Okamoto; M Murakami; A Shimizu; S Ozaki; T Tsubata; S Kumagai; T Honjo
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  7 in total

1.  Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue.

Authors:  T Naito; T Kawamura; M Bannai; T Kosaka; H Kameyama; K Shimamura; O Hoshi; T Ushiki; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Biology of autoreactive extrathymic T cells and B-1 cells of the innate immune system.

Authors:  Toru Abo; Chikako Tomiyama; Hisami Watanabe
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 3.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

Review 4.  Immunologic states of autoimmune diseases.

Authors:  Toru Abo; Toshihiko Kawamura; Hisami Watanabe
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Lyn deficiency affects B-cell maturation as well as survival.

Authors:  Gitit Shahaf; Andrew J Gross; Michal Sternberg-Simon; Deborah Kaplan; Anthony L DeFranco; Ramit Mehr
Journal:  Eur J Immunol       Date:  2011-12-14       Impact factor: 5.532

Review 6.  Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease.

Authors:  Lutz Wollin; Jörg Hw Distler; Christopher P Denton; Martina Gahlemann
Journal:  J Scleroderma Relat Disord       Date:  2019-04-21

7.  Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Authors:  Tâm D Quách; Nely Rodríguez-Zhurbenko; Thomas J Hopkins; Xiaoti Guo; Ana María Hernández; Wentian Li; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.